Nanosonics Limited (NAN) - Announcements

$5.200 0.06 (1.17%)

Latest company announcements for Nanosonics Limited (NAN)

Sector Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
Health Care $1,560 Nanosonics appoints Geoff Wilson as Non-executive Director 17 Jul 2019 8:28AM $5.070 $5.200 $5.250 risen by 2.56%
Health Care $1,560 Appendix 3B 6 Jun 2019 3:31PM $4.385 $5.200 $5.250 risen by 18.59%
Health Care $1,560 Retirement of Non-Executive Director 31 May 2019 8:21AM $4.310 $5.200 $5.250 risen by 20.65%
Health Care $1,560 Ceasing to be a substantial holder from MUFG 7 May 2019 5:28PM $4.710 $5.200 $5.250 risen by 10.40%
Health Care $1,560 Ceasing to be a substantial holder from MS 7 May 2019 8:22AM $4.750 $5.200 $5.250 risen by 9.47%
Health Care $1,560 Change of Director's Interest Notice 1 May 2019 9:01AM $4.940 $5.200 $5.250 risen by 5.26%
Health Care $1,560 Becoming a substantial holder from MUFG 24 Apr 2019 5:13PM $4.570 $5.200 $5.250 risen by 13.79%
Health Care $1,560 Ceasing to be a substantial holder from MUFG 24 Apr 2019 5:11PM $4.570 $5.200 $5.250 risen by 13.79%
Health Care $1,560 Becoming a substantial holder from MS 23 Apr 2019 5:13PM $4.570 $5.200 $5.250 risen by 13.79%
Health Care $1,560 Ceasing to be a substantial holder from MS 23 Apr 2019 4:41PM $4.570 $5.200 $5.250 risen by 13.79%
Health Care $1,560 France issues guidance requiring disinfection of probes 3 Apr 2019 9:42AM $4.470 $5.200 $5.250 risen by 16.33%
Health Care $1,560 Appendix 3B 15 Mar 2019 6:33PM $4.170 $5.200 $5.250 risen by 24.70%
Health Care $1,560 Change of Director's Interest Notice 4 Mar 2019 8:26AM $4.170 $5.200 $5.250 risen by 24.70%
Health Care $1,560 Change of Director's Interest Notice 26 Feb 2019 6:20PM $4.210 $5.200 $5.250 risen by 23.52%
Health Care $1,560 2019 Half Year Financial Results Investor Presentation 25 Feb 2019 8:40AM $3.630 $5.200 $5.250 risen by 43.25%
Health Care $1,560 2019 Half Year Financial Results 25 Feb 2019 8:38AM $3.630 $5.200 $5.250 risen by 43.25%
Health Care $1,560 Appendix 4D and Half Year Report 25 Feb 2019 8:36AM $3.630 $5.200 $5.250 risen by 43.25%
Health Care $1,560 Japanese study demonstrates significant probe contamination 12 Feb 2019 8:51AM $3.410 $5.200 $5.250 risen by 52.49%
Health Care $1,560 Change of Director's Interest Notice 7 Feb 2019 4:55PM $3.430 $5.200 $5.250 risen by 51.60%
Health Care $1,560 Appendix 3B 7 Feb 2019 4:54PM $3.430 $5.200 $5.250 risen by 51.60%
Health Care $1,560 Nanosonics appoints three new senior executives 5 Feb 2019 8:53AM $3.460 $5.200 $5.250 risen by 50.29%
Health Care $1,560 Becoming a substantial holder from MUFG 1 Feb 2019 5:35PM $3.330 $5.200 $5.250 risen by 56.16%
Health Care $1,560 Becoming a substantial holder from MS 1 Feb 2019 1:44PM $3.320 $5.200 $5.250 risen by 56.63%
Health Care $1,560 Change of Director's Interest Notice 16 Jan 2019 9:32AM $3.040 $5.200 $5.250 risen by 71.05%
Health Care $1,560 Change of Director's Interest Notice 30 Nov 2018 7:06PM $3.130 $5.200 $5.250 risen by 66.13%

1 - 25 of 311 results

Page 1 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.